Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/21/2850625/0/en/Senti-Bio-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Reviews-Recent-Highlights.html
https://www.globenewswire.com//news-release/2024/01/05/2804872/0/en/Senti-Bio-Announces-Strategic-Steps-to-Prioritize-Investment-in-Lead-Clinical-Program.html
https://www.globenewswire.com/news-release/2023/12/22/2800521/0/en/Senti-Bio-Announces-FDA-Clearance-of-IND-Application-for-SENTI-202-for-the-Treatment-of-Relapsed-or-Refractory-Hematologic-Malignancies-Including-Acute-Myeloid-Leukemia.html
https://www.globenewswire.com//news-release/2023/11/13/2779496/0/en/Senti-Bio-Announces-Third-Quarter-2023-Results-and-Pipeline-Updates.html
https://www.globenewswire.com//news-release/2023/11/06/2774494/0/en/Senti-Bio-Announces-New-Strategic-Collaboration-with-Celest-Therapeutics-for-Clinical-Development-of-SENTI-301A-in-China.html
https://www.globenewswire.com//news-release/2023/10/31/2770279/0/en/Senti-Bio-Announces-Multiple-Data-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/09/27/2750472/0/en/Senti-Bio-Announces-Multiple-Data-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-2023-Meeting.html
https://www.globenewswire.com//news-release/2023/09/26/2749927/0/en/Senti-Bio-to-Participate-in-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2023/09/05/2737355/0/en/Senti-Bio-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2023/08/11/2723553/0/en/Senti-Bio-Announces-Second-Quarter-2023-Results-and-Pipeline-Updates.html